Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Short term Debt (2025)

AVITA Medical (RCEL) has disclosed Short term Debt for 1 consecutive years, with $43.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short term Debt changed N/A year-over-year to $43.0 million, compared with a TTM value of $43.0 million through Dec 2025, changed N/A, and an annual FY2025 reading of $43.0 million, changed N/A over the prior year.
  • Short term Debt was $43.0 million for Q4 2025 at AVITA Medical, up from $3.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $43.0 million in Q4 2025 and bottomed at $3.0 million in Q1 2025.